Wells Fargo Portfolio holdings
Wells Fargo & Company, founded in 1852 by Henry Wells and William Fargo, is a major American financial institution headquartered in San Francisco, California, known for its extensive retail banking network and historical roots in the American West. Offering a wide range of services—including consumer banking, mortgages, wealth management, and commercial finance—it manages trillions in assets and serves millions of customers through thousands of branches and ATMs across the U.S. Despite its prominence, Wells Fargo faced significant scrutiny following a 2016 scandal involving millions of unauthorized accounts, leading to leadership changes and regulatory penalties, though it has since focused on rebuilding trust and enhancing digital banking capabilities. With a legacy tied to stagecoaches and a modern focus on diversified financial services, Wells Fargo remains a key player in the U.S. banking sector.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$790M |
| 2 |
Invesco Actively Managed Exch-Traded Commodity Fd Tr Invesco Optimum Yield Diversified Commodity Strategy No K-1 ETF
PDBC
|
+$525M |
| 3 |
iShares Broad USD High Yield Corporate Bond ETF
USHY
|
+$479M |
| 4 |
W.W. Grainger
GWW
|
+$286M |
| 5 |
ARK Innovation ETF
ARKK
|
+$244M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$493M |
| 2 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$335M |
| 3 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$314M |
| 4 |
Xtrackers USD High Yield Corporate Bond ETF
HYLB
|
+$275M |
| 5 |
Apple
AAPL
|
+$249M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.74% |
| 2 | Healthcare | 8.69% |
| 3 | Financials | 7.28% |
| 4 | Industrials | 6.31% |
| 5 | Consumer Discretionary | 5.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3976
RxSight
RXST
$293M
| $222K | ﹤0.01% |
18,453
-4,138
| -18% | -$56.8K |
|
3977
BioXcel Therapeutics
BTAI
$28.8M
| $221K | ﹤0.01% |
1,169
+117
| +11% | +$27.2K |
|
3978
PUT
Kinder Morgan
KMI
$70.1B
| $221K | ﹤0.01% |
13,300
-296,800
| -96% | -$5.28M |
|
|
AZEK
3979
DELISTED
The AZEK Co
AZEK
| $220K | ﹤0.01% |
13,219
-2,952
| -18% | -$56.2K |
|
|
CVGW
3980
DELISTED
Calavo Growers
CVGW
| $220K | ﹤0.01% |
6,929
-849
| -11% | -$34.1K |
|
3981
Definitive Healthcare
DH
$67.9M
| $220K | ﹤0.01% |
14,216
+2,617
| +23% | +$57.6K |
|
|
NVRO
3982
DELISTED
NEVRO CORP.
NVRO
| $220K | ﹤0.01% |
4,691
-1,164
| -20% | -$54K |
|
3983
AppFolio
APPF
$7.19B
| $219K | ﹤0.01% |
2,088
-82
| -4% | -$8.36K |
|
3984
Vir Biotechnology
VIR
$1.51B
| $219K | ﹤0.01% |
11,363
-1,385
| -11% | -$35.2K |
|
3985
Schwab Fundamental Emerging Markets Large Company Index ETF
FNDE
$9.96B
| $218K | ﹤0.01% |
9,316
-876
| -9% | -$22.3K |
|
3986
Hawkins
HWKN
$2.71B
| $218K | ﹤0.01% |
5,602
+703
| +14% | +$27.3K |
|
|
STRR
3987
DELISTED
Star Equity Holdings
STRR
| $218K | ﹤0.01% |
43,847
-2
| -0% | -$10 |
|
3988
Unitil
UTL
$981M
| $218K | ﹤0.01% |
4,707
-1,350
| -22% | -$73.1K |
|
|
BLPH
3989
DELISTED
Bellerophon Therapeutics, Inc.
BLPH
| $218K | ﹤0.01% |
200,063
+6
| +0% | +$8 |
|
3990
Dimensional US Targeted Value ETF
DFAT
$14.7B
| $217K | ﹤0.01% |
5,571
-23
| -0.4% | -$981 |
|
3991
Avantis International Small Cap Value ETF
AVDV
$19.8B
| $216K | ﹤0.01% |
4,545
+1,255
| +38% | +$66.5K |
|
3992
BioCryst Pharmaceuticals
BCRX
$2.64B
| $216K | ﹤0.01% |
17,247
-5,425
| -24% | -$69.8K |
|
|
ENFN
3993
DELISTED
Enfusion, Inc.
ENFN
| $216K | ﹤0.01% |
17,514
-308
| -2% | -$3.76K |
|
|
WTER
3994
DELISTED
The Alkaline Water Company Inc. Common Stock
WTER
| $216K | ﹤0.01% |
42,592
+41,362
| +3,363% | +$293K |
|
3995
PUT
First Trust Dow Jones Internet Index Fund ETF
FDN
$5.36B
| $215K | ﹤0.01% |
+1,700
| New | +$237K |
|
3996
Motley Fool 100 Index ETF
TMFC
$2.11B
| $215K | ﹤0.01% |
7,016
-5,648
| -45% | -$194K |
|
|
NSTG
3997
DELISTED
NanoString Technologies, Inc.
NSTG
| $215K | ﹤0.01% |
16,791
-1,368
| -8% | -$19K |
|
3998
The GEO Group
GEO
$4.18B
| $214K | ﹤0.01% |
27,750
-89,768
| -76% | -$662K |
|
3999
Adeia
ADEA
$3.06B
| $213K | ﹤0.01% |
57,044
+2,363
| +4% | +$9.71K |
|
|
JMIA
4000
Jumia Technologies
JMIA
$720M
| $213K | ﹤0.01% |
36,765
-3,301
| -8% | -$22.5K |
|
Similar funds
Wells Fargo's Q3 2022 Portfolio in Review
As of Q3 2022, Wells Fargo held 7,985 positions worth $307B, down 5.1% from $323B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Wells Fargo's Q3 2022 filing shows 269 new, 2,581 increased, 3,682 reduced and 344 closed positions. Its largest new stake was Haleon: 3,382,497 shares worth $20.6M. The largest sale was iShares Core MSCI Emerging Markets ETF, an estimated $493M.
By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 13% a quarter earlier, followed by Healthcare and Financials.
- Wells Fargo's largest Q3 2022 buy was Haleon: 3,382,497 shares worth $20.6M.
- Wells Fargo added most to State Street SPDR S&P 500 ETF Trust in Q3 2022, an estimated $790M increase.
- Wells Fargo's biggest Q3 2022 reduction was iShares Core MSCI Emerging Markets ETF, cutting an estimated $493M.
- Wells Fargo fully exited NextEra Energy, Inc. 4.872% Corporate Units in Q3 2022, selling an estimated $19.1M.
- Wells Fargo's ten largest holdings make up 18% of its $307B portfolio in Q3 2022.
- Wells Fargo opened 269 new positions and closed 344 in Q3 2022.
- Wells Fargo's portfolio value fell 5.1% quarter-over-quarter to $307B.
Based on Wells Fargo's 13F filing for Q3 2022, filed 14 Nov 2022.